Buscar resultados de ensayos clínicos

Patrocinado por

Erythema Multiforme - 15 Studies Found

Estado Estudiar
Completed Nombre del estudio: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Condición: Plaque Psoriasis
Fecha: 2013-06-26
Intervenciones: Drug: Clobex Spray Other Name: Clobetasol propionate spray
Completed Nombre del estudio: A Randomized Two Arm Phase II Trial of Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC
Condición: Stage IV Non-Small Cell Lung Cancer
Fecha: 2016-01-14
Intervenciones:
  • Drug: Pembrolizumab 200mg Pemb
Not yet recruiting Nombre del estudio: Discerning Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Guided Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy
Condición:
  • Prostate Cancer
  • Magnetic Resonance Imaging
  • Device: MRI/ultrasound transperineal fusion-guided prostate biopsy

Completed Nombre del estudio: Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condición: Head and Neck Cancer
Fecha: 2001-08-10
Intervenciones: Drug: liposomal lurtotecan
Active, not recruiting Nombre del estudio: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae)
Condición:
  • Vascular Access Complication
  • Restenosis, Vascular Graft
  • Di
    Fecha: 2017-01-19
    Intervenciones:
    • Device: Conventional angioplasty

Completed Nombre del estudio: HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction
Condición:
  • Stevens-Johnson Syndrome
  • Kidney Failure, Chronic

Fecha: 2017-02-06
Intervenciones: Genetic: HLA-B*5801 test Check whether a participant has HLA-B*5801 allele or not, before administration
Not yet recruiting Nombre del estudio: Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Condición:
  • Stevens-Johnson Syndrome
  • Toxic Epidermal Necrolyses

Fecha: 2016-11-25
Intervenciones:
  • Drug: cyclosporin A Other Name
Completed Nombre del estudio: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Condición:
  • Stevens-Johnson Syndrome
  • Toxic Epidermal Necrolysis

Fecha: 2012-09-20
Intervenciones: Drug: Intravenous immunoglobulin
Completed Nombre del estudio: Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Condición: Stevens-Johnson Syndrome
Fecha: 2010-11-08
Intervenciones: Drug: 0.05%cyclosporin eye drop use twice daily for 6 months
Withdrawn Nombre del estudio: Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Condición:
  • Stevens-Johnson Syndrome
  • Corneal Blindness

Fecha: 2010-11-19
Intervenciones: Drug: Infliximab The drug will be administered intravenously every month for 110 weeks (duration of the
Next >>>